Jin Won Park
Overview
Explore the profile of Jin Won Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee E, Kim H, Suh Y, Park J
Cyberpsychol Behav Soc Netw
. 2022 Jun;
25(8):496-503.
PMID: 35723669
An online experiment ( = 384) examined when and how the identity of the comment moderator (artificial intelligence [AI] vs. human) on a news website affects the extent to which...
2.
Lee J, Lee E, Park J, Kim M, Jung K, Cho Y, et al.
Nucl Med Commun
. 2022 May;
43(8):937-944.
PMID: 35603420
Objective: A better understanding of the metabolic phenotype of stem-like cancer cells could provide targets to help overcome chemoresistance. In this study, we hypothesized that colon cancer cells with the...
3.
Park J, Jung K, Lee J, Moon S, Cho Y, Lee K
Sci Rep
. 2021 Feb;
11(1):3876.
PMID: 33594192
CD44 is a cell-surface glycoprotein involved in cell-cell interaction, adhesion, and migration. CD44 is found on colon cancer cells and on immune cells. Previous studies of Zr PET imaging of...
4.
Lee J, Cho Y, Jung K, Park J, Lee K
Oncol Lett
. 2020 Nov;
20(6):374.
PMID: 33154772
The uncoupling protein-2 (UCP2) serves a role in tumor aggressiveness and anticancer resistance, which is considered to be associated with its ability to attenuate reactive oxygen species (ROS) production. We...
5.
Jung K, Park J, Lee J, Moon S, Cho Y, Lee K
J Nucl Med
. 2020 Sep;
62(5):656-664.
PMID: 32917780
We developed an Zr-labeled anti-programmed death ligand 1 (anti-PD-L1) immune PET that can monitor chemotherapy-mediated modulation of tumor PD-L1 expression in living subjects. Anti-PD-L1 underwent sulfohydryl moiety-specific conjugation with maleimide-deferoxamine...
6.
Lee J, Jung K, Park J, Moon S, Cho Y, Lee K
Sci Rep
. 2020 Sep;
10(1):14308.
PMID: 32868872
We tested the hypothesis that tumor response to conventional bortezomib (BTZ) treatment is enhanced by targeted radiotherapy of resistant cancer stem cells (CSCs) that have characteristically poor proteasome function. This...
7.
Park J, Hong S, Lee J, Moon S, Cho Y, Jung K, et al.
PLoS One
. 2020 Feb;
15(2):e0228848.
PMID: 32050000
We investigated the relation of 99mTc-MIBI uptake to mitochondrial membrane potential (MMP) in cancer cell lines and patient-derived tumor cells (PDCs). In T47D and HT29 cells with low MDR1 expression,...
8.
Park J, Choi H
Clin Exp Emerg Med
. 2020 Jan;
6(4):351-355.
PMID: 31910507
Objective: Several environmental factors influence the prehospital use of video laryngoscopes (VLs). For example, fogging of the VL lens can occur in cold environments, and the low temperature can cause...
9.
Jung K, Lee E, Park J, Lee J, Moon S, Cho Y, et al.
PLoS One
. 2019 Sep;
14(9):e0221294.
PMID: 31532771
Breast cancers that express epidermal growth factor (EGF) receptors (EGFRs) are associated with poor prognosis. Our group recently showed in breast cancer patients that EGFR expression is strongly correlated with...
10.
Park J, Jung K, Byun Y, Lee J, Moon S, Cho Y, et al.
Sci Rep
. 2019 Apr;
9(1):6462.
PMID: 31015586
Aldehyde dehydrogenase (ALDH) assays measure the accumulated fluorescence of enzyme products. However, cancer cells frequently co-express ALDH and ATP-binding cassette (ABC) transporters, which might mediate efflux of ALDH assay reagents....